ALEC
Price:
$1.92
Market Cap:
$188.03M
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's...[Read more]
Industry
Biotechnology
IPO Date
2019-02-07
Stock Exchange
NASDAQ
Ticker
ALEC
According to Alector, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 185.51M. This represents a change of -63.71% compared to the average of 511.12M of the last 4 quarters.
The mean historical Enterprise Value of Alector, Inc. over the last ten years is 973.44M. The current 185.51M Enterprise Value has changed 1.81% with respect to the historical average. Over the past ten years (40 quarters), ALEC's Enterprise Value was at its highest in in the June 2020 quarter at 1.87B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.
Average
973.44M
Median
955.83M
Minimum
632.56M
Maximum
1.38B
Discovering the peaks and valleys of Alector, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 30.97%
Maximum Annual Enterprise Value = 1.38B
Minimum Annual Increase = -52.85%
Minimum Annual Enterprise Value = 632.56M
Year | Enterprise Value | Change |
---|---|---|
2023 | 632.56M | -2.71% |
2022 | 650.18M | -52.85% |
2021 | 1.38B | 17.09% |
2020 | 1.18B | 15.23% |
2019 | 1.02B | -12.28% |
2018 | 1.17B | 30.97% |
2017 | 889.57M | 2.11% |
The current Enterprise Value of Alector, Inc. (ALEC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
887.27M
5-year avg
972.33M
10-year avg
973.44M
Alector, Inc.’s Enterprise Value is greater than Passage Bio, Inc. (33.56M), greater than Black Diamond Therapeutics, Inc. (123.50M), greater than TCR2 Therapeutics Inc. (79.12M), less than Harpoon Therapeutics, Inc. (861.85M), less than Revolution Medicines, Inc. (7.90B), greater than Atreca, Inc. (-8620212.00), less than Stoke Therapeutics, Inc. (467.23M), greater than Homology Medicines, Inc. (-103303255.00), less than Monte Rosa Therapeutics, Inc. (356.78M), greater than Cabaletta Bio, Inc. (-40033808.00), less than Larimar Therapeutics, Inc. (222.97M),
Company | Enterprise Value | Market cap |
---|---|---|
33.56M | $40.03M | |
123.50M | $123.92M | |
79.12M | $58.11M | |
861.85M | $865.08M | |
7.90B | $8.01B | |
-8620212.00 | $3.57M | |
467.23M | $614.95M | |
-103303255.00 | $3.02M | |
356.78M | $438.66M | |
-40033808.00 | $115.35M | |
222.97M | $252.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alector, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alector, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Alector, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Alector, Inc. (ALEC)?
What is the 3-year average Enterprise Value for Alector, Inc. (ALEC)?
What is the 5-year average Enterprise Value for Alector, Inc. (ALEC)?
How does the current Enterprise Value for Alector, Inc. (ALEC) compare to its historical average?